You are here

  • Home
  • Archive
  • Volume 72, Issue Suppl 3
  • P270 Identification of responder groups to fluticasone furoate/vilanterol (ff/vi) in the salford lung study in copd (sls copd) using a cluster analysis model

Article Text

Article menu

Download PDFPDF

Declarations of Interest
P270 Identification of responder groups to fluticasone furoate/vilanterol (ff/vi) in the salford lung study in copd (sls copd) using a cluster analysis model
Free

Abstract

A Nicholls: Employment and stock ownership (GSK)

N Diar Bakerly: Employing organisation provided IT support to automated data collection method for the SLS COPD trial. NDB received financial support to attend meeting in the form of non-restricting educational grants from GSK, Novartis, Astra Zeneca and BI

S Collier: Employment and stock ownership (GSK)

H Dickinson: Employment and stock ownership (GSK)

D Leather: Employment and stock ownership (GSK)

I Boucot: Employment and stock ownership (GSK)

https://doi.org/10.1136/thoraxjnl-2017-210983.469

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.